DVA - DaVita Inc Stock Analysis
DaVita Inc (DVA) is a publicly traded company listed on the Large. It operates in the Medical Care Facilities industry, part of the broader Healthcare sector. The company has a market capitalization of 12.81B, generates annual revenue of 13.84B, and reports net income of 756.42M. As of the latest data, the stock is trading at 199.52 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock appears reasonably valued, potentially indicating balanced risk and return. The PEG ratio is below 1, which may indicate the stock is undervalued relative to its growth potential. The company has very low leverage, which may indicate conservative financial management or underutilization of debt. The dividend yield (0.84%) is modest, often associated with growth-oriented companies. The stock has average market volatility, aligning with general market movement.
Analyst recommendation stands at Hold (3.43), indicating current market sentiment. Institutional ownership is reported at 96.34%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 37.21%, trading within a 52-week range of 101.00 - 202.69.
DVA - DaVita Inc
199.52
Analyst Consensus
Hold 3.43
DVA – Analyst Rating Summary
- Strong Buy: 1
- Buy: 5
- Hold: 7
- Sell: 1
- Strong Sell: 0
- Total Analysts: 14
| Index: | S&P 500 | P/E: | 19.15 | EPS (ttm): | 10.42 | Insider Own: | 2.20% | Shs Outstand: | 66.19M | Perf Week: | 0.30% |
| Market Cap: | 12.81B | Forward P/E: | 11.73 | EPS next Y: | 17.01 | Insider Trans: | -67.76% | Shs Float: | 62.79M | Perf Month: | 34.89% |
| Income(ttm): | 756.42M | PEG: | 0.60 | EPS next Q: | 3.81 | Inst Own: | 96.34% | Short Float: | 9.96% | Perf Quarter: | 32.65% |
| Revenue(ttm): | 13.84B | P/S: | 0.93 | EPS this Y: | 36.38% | Inst Trans: | -1.06% | Short Ratio: | 7.23 | Perf Half Y: | 62.15% |
| Book/sh: | -11.41 | P/B: | - | EPS next Y: | 15.68% | ROA: | 4.37% | Short Interest: | 6.25M | Perf Year: | 37.21% |
| Cash/sh: | 11.66 | P/C: | 17.11 | EPS next 5Y: | 19.63% | ROE: | 635.30% | 52W Range: | 101.00 - 202.69 | Perf YTD: | 75.62% |
| Dividend Est.: | 1.67 (0.84%) | P/FCF: | 8.58 | EPS past 3/5Y: | 18.56% 8.29% | ROIC: | 6.35% | 52W High: | 202.69 -1.56% | Beta: | 0.87 |
| Dividend TTM: | - | Quick Ratio: | 1.37 | Sales past 3/5Y: | 5.53% 3.39% | Gross Margin: | 27.27% | 52W Low: | 101.00 97.54% | Perf 5Y: | 63.35% |
| Dividend Ex-Date: | - | Current Ratio: | 1.42 | EPS Y/Y TTM: | 2.79% | Oper. Margin: | 14.82% | RSI (14): | 75.31 | Volatility: | 3.21% 3.61% |
| Employees: | 78000 | Debt/Eq: | - | Sales Y/Y TTM: | 6.68% | Profit Margin: | 5.47% | Recom: | 2.60 | Target Price: | 200.00 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | - | EPS Q/Q: | 43.08% | Payout: | 0.00% | Rel Volume: | 0.97 | Prev Close: | 199.74 |
| Sales Surprise: | 1.76% | EPS Surprise: | 23.18% | Sales Q/Q: | 5.96% | Earnings: | May 05 AMC | Avg Volume: | 865.14K | Price: | 199.52 |
| SMA20: | 15.42% | SMA50: | 25.01% | SMA200: | 47.36% | Overbought: -0.24% | Volume: | 836,729 | Change: | -0.11% | |
Graham Classic formula value: 446.88
(P/E=8 * 1g) Min value: 258.53
(current P/E * 2g) Max value: 546.53
Average value: 417.31
About DaVita Inc
DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.